The promoter of human tissue factor pathway inhibitor gene: Identification of potential regulatory elements

Thrombosis Research

Volumn 95, Issue 5, 1999, Pages 255-262

  Petit, Laure ^a   Lesnik, Philippe ^a   Dachet, Christiane ^a   Hugou, Isabelle ^a   Moreau, Martine ^a   Chapman, John ^a   Rouis, Mustapha ^a  

^a INSERM   (France)

Author keywords

ECV304; HepG2; Promoter; THP1; Tissue factor pathway inhibitor; Transfection

Indexed keywords

BLOOD CLOTTING INHIBITOR; TAQ POLYMERASE; TISSUE FACTOR PATHWAY INHIBITOR;

ARTICLE; BLOOD CLOTTING; CELL STRAIN HEPG2; CONSENSUS SEQUENCE; CONTROLLED STUDY; DNA TRANSFECTION; GENE CONTROL; GENE LOCATION; HUMAN; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TRANSCRIPTION INITIATION;

BASE SEQUENCE; CELL LINE; GENE EXPRESSION REGULATION; HUMANS; LIPOPROTEINS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); SEQUENCE ANALYSIS, DNA;

EID: 0032819501     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(99)00040-7     Document Type: Article

References (39)

1. Rapaport S.I., Rao L.V.M. Initiation and regulation of tissue factor-dependent blood coagulation. Arterioscler Thromb. 12:1992;1111-1121.
2. Edwards R.L., Rickles F.R., Cronland M. Abnormalities of blood coagulation in patients with cancer. Mononuclear cell tissue factor generation. J Lab Clin Med. 98:1981;917-928.
3. Lyberg T., AmLie E., Kaplan A., Prydz H. Macrophage heterogeneity in thromboplastin response. Scand J Immunol. 18:1983;235-240.
4. Wilcox J.H., Smith K.M., Schwartz S.M., Gordon D. Localization of tissue factor in the normal vessel wall and in atherosclerotic plaques. Proc Natl Acad Sci USA. 86:1989;2839-2843.
5. Rapaport S.I. The extrinsic pathway inhibitor- A regulator of tissue factor dependent blood coagulation. Thromb Haemost. 66:1991;6-15.
6. Broze G.J.J., Girard T.J., Novotny W.F. Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochemistry. 29:1990;7539-7546.
7. Sandset P.M., Warn-Cramer B.J., Rao L.V.M., Maki S.I., Rapaport S.I. Depletion of extrinsic pathway inhibitor (EPI) sensitizes rabbits to desseminated intravascular coagulation induced with tissue factor. Evidence supporting physiologic role for EPI as a natural anticoagulant Proc Natl Acad Sci USA. 88:1991;708-712.
8. Wun T.C., Huang M.D., Kretzmer K.K. Immunoaffinity purification and characterization of lipoprotein-associated coagulation inhibitors from HepG2 hepatoma, Chang liver, and SK hepatoma cells. J Biol Chem. 27:1989;16096-16101.
9. Novotny W.F., Girard T.J., Miletich J.P., Broze G.J.J. Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor. Blood. 72:1988;2020-2025.
10. Bajaj M.S., Kuppuswamy M.N., Saito H., Spitzer S.G., Bajaj S.P. Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor. Evidence that endothelium is the principal site of its synthesis Proc Natl Acad Sci USA. 87:1990;8869-8873.
11. Rana S.V., Reamers H.J., Pathikonda M.S., Bajaj S.P. Expression of tissue factor and factor VIIa/tissue factor inhibitor activity in endotoxin or phorbol ester stimulated U937 monocyte-like cells. Blood. 71:1988;259-262.
12. Lindahl A.R., Sandset P.M., Abildgaard U. The present status of tissue factor pathway inhibitor. Blood Coag Fibrinol. 3:1992;439-449.
13. Van der Logt C.P.E., Dirven R.J., Reitsma P.H., Bertina R.M. Expression of tissue factor and tissue factor pathway inhibitor in monocytes in response to bacterial lipopolysaccharide and phorbol ester. Blood Coag Fibrinol. 5:1994;211-220.
14. McGee M.P., Foster S., Wang X. Simultaneous expression of tissue factor and tissue factor pathway inhibitor by human monocytes. A potential mechanism for localized control of blood coagulation. J Exp Med. 179:1994;1847-1854.
15. Drew A.F., Davenport P., Apostolopoulos J., Tipping P.G. Tissue factor pathway inhibitor expression in atherosclerosis. Lab Invest. 77:1997;291-298.
16. Petit L., Lesnik P., Dachet C., Moreau M., Chapman J. Tissue factor pathway inhibitor is expressed by human monocyte-derived macrophages. Relationship to tissue factor induction by cholesterol and oxidized LDL Arterioscler Thromb Vasc Biol. 19:1999;309-315.
17. Van der Logt C.P.E., Reitsma P.H., Bertina R.M. Intron-exon organization of the human gene coding for the lipoprotein-associated coagulation inhibitor. The factor Xa dependent inhibitor of the extrinsic pathway of coagulation Biochemistry. 30:1991;1571-1577.
18. Girard T.G., Eddy R., Wesselschmidt R.L., MacPhail L.A., Likert K.M., Byers M.G., Shows T.B., Broze G.J.J. Structure of the human lipoprotein-associated coagulation inhibitor gene. J Biol Chem. 266:1991;5036-5041.
19. Tyson D.R., Kuppuswamy M.N., Broze G.J.J., Bajaj S.P. Revised DNA sequence of exon 1 and 5′ flanking region of the human tissue factor pathway inhibitor gene. Thromb Res. 70:1993;269-273.
20. Wun T.-C., Kretzmer K., Girard T.J., Miletich J.P., Broze G.J.J. Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory damains. J Biol Chem. 13:1988;6001-6004.
21. Sanger F., Nicklen S., Coulson A.R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA. 74:1977;5463-5467.
22. Carlsson P., Bjursell G. Negative and positive promoter elements contribute to tissue specificity of apolipoprotein B expression. Gene. 77:1989;113-121.
23. Oeth P., Parry G.C.N., Mackman N. Regulation of the tissue factor gene in human monocytic cells. Arterioscler Thromb Vasc Biol. 17:1997;365-374.
24. Prestridge D.S. Signal Scan. A computer program that scans DNA sequences for eukaryotic transcriptional elements CABIOS. 7:1991;203-206.
25. Lee M.-E., Temizer D.H., Clifford J.A., Quertermous T. Cloning of the GATA-binding protein that regulates endothelin-1 gene expression in endothelial cells. J Biol Chem. 266:1991;16188-16192.
26. Martin D.I.K., Zon L.I., Mutter G., Orkin S.H. Expression of an erythroid transcription factor in megakaryotic and mast cell lineages. Nature. 344:1990;444-447.
27. Wilson D.M., Dorfman D.M., Orkin S.H. A nonerythroid GATA-binding protein is required for function of the human preproendothelin-1 promoter in endothelial cells. Mol Cell Biol. 10:1990;4854-4862.
28. Dynan W.S., Tjian R. The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter. Cell. 35:1983;79-87.
29. Dynan W.S., Tijan R. Control of eucaryotic messenger RNA synthesis by sequence-specific DNA-binding proteins. Nature. 316:1985;774-778.
30. Gidoni D., Dynan W.S., Tjian R. Multiple specific contacts between a mammalian transcription factor and its cognate promoter. Nature. 312:1984;409-413.
31. Gidoni D., Kadonaga J.T., Barerra-Saldana H., Takahashi K., Chambon P., Tjian R. Bidirectional SV40 transcription mediated by tandem Sp1 binding interactions. Science. 230:1985;511-517.
32. Boisclair Y.R., Brown A.L., Casola S., Rechler M. Three clustered Sp1 sites are required for efficient transcription of the TATA-less promoter of the gene for insulin-like growth factor-binding protein-2 from the rat. J Biol Chem. 268:1993;24892-24901.
33. Joel P., Shao W., Pratt K. A nuclear protein with enhanced binding to methylated Sp1 sites in the AIDS virus promoter. Nucleic Acids Res. 21:1993;5786-5793.
34. Husmann M., Jehnichen P., Jahn B., Schlosshan D., Romahn E., Marx J. A novel SP-1 site in the human interleukin-1 beta promoter confers preferential transcriptional activity in keratinocytes. Eur J Immunol. 26:1996;3008-3014.
35. Lecointe N., Bernard O., Naert K., Joulin V., Larsen C.J., Romeo P.H., Mathieu-Mahul D. GATA-and SP1-binding sites are required for the full activity of the tissue-specific promoter of the tal-1 gene. Oncogene. 9:1994;2623-2632.
36. Zhang R., Min W., Sessa W.C. Functional analysis of the human endothelial nitric oxide synthase promoter. Sp1 and GATA factors are necessary for basal transcription in endothelial cells. J Biol Chem. 270:1995;15320-15326.
37. Fischer K.D., Haese A., Nowock J. Cooperation of GATA-1 and Sp1 can result in synergistic transcriptional activation or interference. J Biol Chem. 268:1993;23915-23923.
38. Hoey T., Weinzierl R.O., Gill G., Chen J.L., Dynlacht B.D., Tjian R. Molecular cloning and functional analysis of Drosophila TAF110 reveal properties expected of coactivators. Cell. 72:1993;247-260.
39. Pugh B.F., Tjian R. Transcription from a TATA-less promoter requires a multisubunit TFIID complex. Genes Dev. 5:1991;1935-1945.